Frontiers in Hematology

Community Case Study

Published on 25 Jul 2024

Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study

in Blood Cancer

Barbara Loteta
Annalisa Pitino
Martina Pitea
Caterina Alati
Giovanni Tripepi
Maria Caterina Mico'
Maria Pellicano'
Francesca Cogliandro
Gaetana Porto
Giorgia Policastro

Frontiers in Hematology

doi 10.3389/frhem.2024.1441070

876 views

Mini Review

Published on 22 Jul 2024

Targeting the bone marrow niche, moving towards leukemia eradication

in Blood Cancer

Carla Semedo
Raquel Caroço
António Almeida
Bruno António Cardoso

Frontiers in Hematology

doi 10.3389/frhem.2024.1429916

1,917 views

Original Research

Published on 15 Jul 2024

Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States

in Hematopoiesis and Stem Cells

Yan Wang
Andrew Rava
Marlene Smurzynski
Bonny Shah
Anusorn Thanataveerat
Imad Al-Dakkak
Moh-Lim Ong
Christopher C. Dvorak
Vincent T. Ho

Frontiers in Hematology

doi 10.3389/frhem.2024.1405311

3,755 views

Review

Published on 12 Jul 2024

Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets

in Blood Cancer

Cristian C. Taborda
Amer M. Zeidan
Lourdes M. Mendez

Frontiers in Hematology

doi 10.3389/frhem.2024.1419323

3,544 views
1 citation

Case Report

Published on 10 Jul 2024

Case report: Aggressive natural killer cell leukemia and refractory hemophagocytic lymphohistiocytosis in an adolescent

in Blood Cancer

Caroline Spaner
Jessica Durkee-Shock
Andrew Weng
Ryan Stubbins
Alina S. Gerrie
Stefania Pittaluga
Jeffrey I. Cohen
Luke Y. C. Chen

Frontiers in Hematology

doi 10.3389/frhem.2024.1413794

1,201 views

Review

Published on 08 Jul 2024

The sweet symphony of N-glycans in myeloid malignancies

in Blood Cancer

Javier Sanmartín-Martínez
Valerie R. Wiersma
Anna E. Marneth

Frontiers in Hematology

doi 10.3389/frhem.2024.1415618

1,056 views
1 citation

Mini Review

Published on 05 Jul 2024

Congenital dyserythropoietic anemia type II and ineffective erythropoiesis: challenges in diagnosis and management

in Red Cells, Iron and Erythropoiesis

Imo J. Akpan
Kelsie Bogyo
Rebecca J. Leeman-Neill
Julia Wattacheril
Richard O. Francis

Frontiers in Hematology

doi 10.3389/frhem.2024.1389820

1,914 views
1 citation

Original Research

Published on 20 Jun 2024

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

in Blood Cancer

Vittorio Del Fabro
Uros Markovic
Sara Frazzetto
Roberta Sciortino
Claudia Bellofiore
Mary Ann Di Giorgio
Valerio Leotta
Anna Bulla
Angelo Curto Pelle
Federica Elia

Frontiers in Hematology

doi 10.3389/frhem.2024.1425677

895 views

Brief Research Report

Published on 17 Jun 2024

Novel cryopreservation medium for enhanced stability of T cells at −80°C

in Immunobiology and Immunotherapy

WenXuan Zhou
Chen Wang
Yao Shi
Yi Pan
XiaDuo Meng
XunLei Kang
Xu Han

Frontiers in Hematology

doi 10.3389/frhem.2024.1346627

2,175 views
2 citations

Brief Research Report

Published on 13 Jun 2024

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

in Blood Cancer

Theo Leitner
Cyrus Khandanpour
Knut Wendelin
Fuat Oduncu
Christoph Kimmich
Ralph Naumann
Miriam Kull
Hartmut Goldschmidt
Martin Ehmer
Claudia Kiewitz

Frontiers in Hematology

doi 10.3389/frhem.2024.1335161

967 views

Mini Review

Published on 28 May 2024

Exploring extramedullary hematopoiesis: unraveling the hematopoietic microenvironments

in Hematopoiesis and Stem Cells

Guadalupe Rivera-Torruco
Marcus O. Muench
Ricardo Valle-Rios

Frontiers in Hematology

doi 10.3389/frhem.2024.1371823

3,848 views
1 citation

Original Research

Published on 10 May 2024

Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis

in Red Cells, Iron and Erythropoiesis

Friederike Poppenborg
Alexander Röth
Raina Yamamoto
Hans Christian Reinhardt
Ferras Alashkar

Frontiers in Hematology

doi 10.3389/frhem.2024.1374181

1,616 views
2 citations

Review

Published on 08 May 2024

AL amyloidosis: an overview on diagnosis, staging system, and treatment

in Blood Cancer

Sonia Morè
Valentina Maria Manieri
Laura Corvatta
Erika Morsia
Antonella Poloni
Massimo Offidani

Frontiers in Hematology

doi 10.3389/frhem.2024.1378451

3,453 views
1 citation

Brief Research Report

Published on 26 Apr 2024

Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma

in Hematopoiesis and Stem Cells

Flavia Bigi
Paola Tacchetti
Alessandro Giorgi
Gaia Mazzocchetti
Vincenza Solli
Simona Barbato
Barbara Sinigaglia
Elena Campanini
Emanuele Favero
Marco Talarico

Frontiers in Hematology

doi 10.3389/frhem.2024.1386973

1,007 views
2 citations

Original Research

Published on 18 Apr 2024

Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis

in Red Cells, Iron and Erythropoiesis

Laura Pelagatti
Giulia Pozzi
Samuele Cortellazzi
Cristina Mancini
Eugenia Martella
Luca Pagliaro
Mariateresa Giaimo
Giovanni Roti
Marco Vitale
Cecilia Carubbi

Frontiers in Hematology

doi 10.3389/frhem.2024.1356561

1,664 views

Brief Research Report

Published on 09 Apr 2024

Evaluating the effectiveness of COVID-19 vaccines in adults with sickle cell disease during the Omicron period of COVID-19 pandemic

in Red Cells, Iron and Erythropoiesis

Kim Abbegail Tan Aldecoa
Chef Stan L. Macaraeg
Camelia Arsene
Geetha Krishnamoorthy
Tiffany Chng
Garrett Cherry
Nabila Chowdhury
Ryan Clark
Dana Deeb
Lisa Deptula

Frontiers in Hematology

doi 10.3389/frhem.2024.1365268

903 views